Israel Allows Stem Cell-Based Drug Against COVID-19 To Enter Phase 2 Trials - Reports
Muhammad Irfan Published August 12, 2021 | 01:30 AM
TEL AVIV (UrduPoint News / Sputnik - 12th August, 2021) The Israeli Health Ministry has given permission to biotech company Bonus BioGroup to begin Phase 2 trials of its COVID-19 drug based on stem cells, the Yedioth Ahronoth newspaper reported on Wednesday.
In July, Israeli company Bonus BioGroup told Sputnik that it had successfully concluded Phase 1 trials of the drug, which were conducted at Rambam hospital in Haifa.
According to the developers, three shots of the drug injected within 24 hours bring oxygen level in COVID-19 patient back to normal and significantly improve their well-being.
Phase 2 trials will take place in Israel and involve 60 people experiencing severe cases of COVID-19. They will be followed by Phase 3 trials, which will include some 300 patients from different countries.
The drug is produced from stem cells taken from healthy people, which then undergo treatment in a bioreactor. The entire process takes roughly 10 days.
Recent Stories
President Raisi leaves for Iran from Karachi
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 24 April 2024
Today Gold Rate in Pakistan 24 April 2024
Punjab CM inaugurates Pakistan’s first Virtual Women Police Station
Dutch model Donny Roelvink embraces Islam
Experts raise concerns over introduction of 10-stick packs
Iranian president arrives in Karachi
Law Minister expresses Govt's resolve to address issue of missing persons
Rizwan’s batting order may be changed: Sources
Nawaz Sharif to visit Guangzhou exhibition in China
FM Dar not traveling to China: Foreign Office
PM takes notice of deliberate delay in tax cases
More Stories From World
-
Doncic shines as Mavs sink Clippers; Timberwolves down Suns
15 minutes ago -
Israel says US military aid sends 'strong message' to enemies
1 hour ago -
Under stress of war, gambling grips Ukrainian soldiers
1 hour ago -
Long-delayed Ukraine aid clears US Congress, awaits Biden signature
2 hours ago -
Up the Congo River on an eventful voyage aboard 'God's Miracle'
2 hours ago -
A 'healthy addiction': sea saunas make waves in Ireland
2 hours ago
-
Victims of China floods race to salvage property
2 hours ago -
China to send fresh crew to Tiangong space station
3 hours ago -
Norman says McIlroy welcome on LIV Tour, but denies any offer
3 hours ago -
China, future HQ: New ASML boss faces bulging in-tray
3 hours ago -
Trump meets former Japanese prime minister in New York
3 hours ago -
'Catch and Kill' architect details Trump-boosting scheme
3 hours ago